-
Morgan Stanley Upgrades Globus Medical, Expects 17% Upside
Tuesday, January 2, 2018 - 11:32am | 479Read More...Globus Medical Inc (NASDAQ: GMED), a medical device company that's among the major players in spine robotic surgery technologies, saw its stock gain more than 70 percent in 2017, and one analyst projects more upside in 2018. The Analyst Morgan Stanley's Jonathan Demchick...
-
Intuitive Surgical's Sp Ushers In The Next Phase Of Growth Story
Monday, May 22, 2017 - 10:11am | 486Read More...Morgan Stanley analysts David Lewis and Jonathan Demchick raised their price target on Intuitive Surgical, Inc. (NASDAQ: ISRG) from $840 to $950. The analysts maintain an Overweight rating. Lewis and Demchick highlighted Intuitive posted five straight quarters of company-adjusted procedure...
-
Hill-Rom Story Not Appreciated By Wall Street, Says Morgan Stanley
Thursday, June 16, 2016 - 9:02am | 298Read More...Morgan Stanley analysts David Lewis and Jonathan Demchick believe Hill-Rom Holdings, Inc. (NYSE: HRC)'s story has not been fully appreciated by the Street. The analysts placed this opinion against the backdrop of the company's recent creation of a more sustainable sales base, which boosts the...
